States Parties are recommended to use an integrated approach to respiratory infectious disease surveillance that leverages the Global Influenza Surveillance and Response system.
4922
以及了解所有地区的COVID-19负担。
Surveillance should incorporate information from representative sentinel populations, event-based surveillance, human wastewater surveillance, sero-surveillance, and animal-human-environmental surveillance.
4923
建议缔约国利用全球流感监测和应对系统，采用综合方法进行呼吸道传染病监测。
WHO should continue to work with Member States to ensure adequate capacity and coverage of COVID-19 surveillance are in place to recognise quickly any significant changes in the virus and/or its epidemiology and clinical impact including hospitalization, so that WHO can trigger appropriate global alerting as necessary.
States Parties should enhance access to COVID-19 vaccines, diagnostics and therapeutics, and consider preparing for these medical countermeasures to be authorized outside of Emergency Use Listing procedures and within normal national regulatory frameworks.
4927
疗法与2019冠状病毒病（COVID-19）：动态指南；
(Therapeutics and COVID-19: living guideline; COVID-19 Clinical Care Pathway)
4928
保持强大的国家应对能力并且未雨绸缪，以防出现恐慌-忽视循环。
Maintain strong national response capacity and prepare for future events to avoid the occurrence of a panic-neglect cycle.
States Parties should consider how to strengthen country readiness to respond to outbreaks including attention to health workforce capacity, infection prevention and control, and financing for respiratory and non-respiratory pathogen preparedness and response.